BioLineRx Ltd. Gains 33.78%
Fri, Oct 30, 2020 at 05:30 PM
BioLineRx Ltd. (BLRX:NASDAQ) shot up at $1.98, a gain of 33.8%. On Thu 29 Oct 20, BLRX:NASDAQ hit a New 2-Week Intraday Low of $1.45. The stock got featured on our News Catalysts scanner on Fri 30 Oct 20 at 01:21 PM in the 'BIOTECH' category. From Thu 15 Oct 20, the stock recorded 20.00% Up Days and 18.18% Green Days
The stock spiked on Wed 05 Aug 20 at $2.57 with a volume of 1M+, and its share price has been moving sideways in recent weeks.
About BioLineRx Ltd. (BLRX:NASDAQ)
BioLine Rx Ltd is a clinical stage biopharmaceutical development company engaged in identifying, in-licensing & developing therapeutic compounds.
Top 10 Gainers:
- BioLineRx Ltd. (BLRX:NASDAQ), 33.78%
- Tricida, Inc. (TCDA:NASDAQ), 28.83%
- Air Industries Group (AIRI:NYSEMKT), 27.82%
- Daseke, Inc. (DSKE:NASDAQ), 26.59%
- Build-A-Bear Workshop, Inc. (BBW:NYSE), 24.4%
- Acadia Healthcare Company, Inc. (ACHC:NASDAQ), 23.02%
- Novus Therapeutics, Inc. (NVUS:NASDAQ), 22.22%
- MICT, Inc. (MICT:NASDAQ), 21.88%
- CASI Pharmaceuticals, Inc. (CASI:NASDAQ), 21.76%
- LNSR (LNSR:NASDAQ), 19.61%